Mortgage Blog How a potential $1.2B cancer drug deal helps this Newark biotech target diseases of aging firststargroup July 6, 2022 The deal is the third over the past year by the team behind Newark-based Teneobio.
The deal is the third over the past year by the team behind Newark-based Teneobio.
